The Journal of Heart and Lung Transplantation
Volume 21, Issue 11 , Pages 1161-1173 , November 2002

Recipient selection in cardiac transplantation: contraindications and risk factors for mortality

  • Thomas R Cimato, MD, PhD

      Affiliations

    • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    • ,
  • Mariell Jessup, MD

      Affiliations

    • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    • Corresponding Author InformationReprint requests: Dr. Mariell Jessup, Heart Failure/Transplant Program, Hospital of the University of Pennsylvania, 6 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA. Telephone: 215-615-0800. Fax: 215-615-0828.

Received 20 September 2001 ,Revised 18 December 2001 ,Accepted 1 February 2002.

References 

  1. Borkon AM, Muehlebac GF, Jones PG, et al.  An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 1999;18:668–674
  2. Costanzo MR, Augustine S, Bouge R, et al.  Selection and treatment of candidates for heart transplantation. Circulation. 1995;92:3593–3612
  3. From the Association AH. Heart and stroke Facts 2000 statistical update www.americanheart.org.
  4. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society of Heart and Lung Transplantation (seventeenth official report—2000). J Heart Lung Transplant. 2000;19:909–931
  5. Adajar F, Lawless C, Malinowska K. Outcome of heart transplant patients with renal insufficiency. J Heart Lung Transplant. 2001;20:248
  6. Herrmann M, Weyand M, Greshake B, et al.  Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 1997;95:814–817
  7. Pelosi FJ, Capehart J, Roberts WC. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis. Am J Cardiol. 1997;79:532–535
  8. Hosenpud JD, DeMarco T, Frazier OH, et al.  Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation (Follow-up results of a multicenter survey). Circulation. 1991;84:III338–343
  9. Dubrey SW, Burke MM, Khaghani A, Hawkins PN, Yacoub MH, Banner NR. Long term results of heart transplantation in patients with amyloid heart disease. Heart. 2001;85:202–207
  10. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation. 1990;49:354–358
  11. Hosenpud JD, Pamidi SR, Fiol BS, Cinquegrani MP, Keck BM. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation (an analysis and study using the joint ISHLT/UNOS thoracic registry). J Heart Lung Transplant. 2000;19:781–785
  12. Castella M, Tenderich G, Koerner MM, et al.  Outcome of heart transplantation in patients previously infected with hepatitis C virus. J Heart Lung Transplant. 2001;20:595–598
  13. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Lung Transplant. 1988;7:331–336
  14. Erickson KW, Costanzo-Nordin MR, O’Sullivan EJ, et al.  Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Lung Transplant. 1990;9:526–537
  15. Costard-Jackle A, Hill I, Schroeder IA, Fowler MB. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation. 1991;84:III-329–337
  16. Adamson RM, Dembitsky WP, Jaski BE, et al.  Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASAIO J. 1997;43:365–369
  17. O’Connell JB, Dec GW, Goldenberg IF, et al.  Results of heart transplantation for active lymphocytic myocarditis. J Heart Lung Transplant. 1990;9:351–356
  18. Bourge RC, Kirklin JK, Naftel DC, McGiffin DC. Predicting outcome after cardiac transplantations (lessons from the Cardiac Transplant Research Database). Curr Opin Cardiol. 1997;12:136–145
  19. McCarthy JF, McCarthy PM, Massad MG, et al.  Risk factors for death after heart transplantation (does a single-center experience correlate with multicenter registries?). Ann Thorac Surg. 1998;65:1574–1579
  20. Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Pretransplantation risk factors for death after heart transplantation (the Henri Mondor experience). J Heart Lung Transplant. 1998;17:268–277
  21. Aziz T, El-Gamel A, Krysiak P, et al.  Ten year experience in orthotopic heart transplantation (single center result). Transplant Proc. 1998;30:1915–1916
  22. Espinoza C, Manito N, Castells E, et al.  Pretransplant risk factors of early mortality after orthotopic heart transplantation. Transplant Proc. 1999;31:2507–2508
  23. John R, Rajasinghe HA, Itescu S, et al.  Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol. 2001;37:189–194
  24. Crespo-Leiro MG, Panigua MJ, Rodriguez JA, et al.  Morbidity and mortality among heart transplant patients older and younger than 65 years. Transplant Proc. 1999;31:2537–2538
  25. Rickenbacher PR, Lewis NP, Valantine HA, Luikart H, Stinson EB, Hunt SA. Heart transplantation in patients over 54 years of age. Eur Heart J. 1997;18:870–878
  26. Baron O, Trochu M, Treilhaud O, et al.  Cardiac transplantation in patients over 60 years of age. Transplant Proc. 1999;31:75–78
  27. John R, Lietz K, Schuster M, et al.  Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation. J Heart Lung Transplant. 2001;20:212
  28. Esmore D, Keogh A, Spratt P, Jones B, Chang V. Heart transplantation in females. J Heart Lung Transplant. 1991;10:335–341
  29. Fabbri A, Bryan AJ, Sharples LD, et al.  Influence of recipient and donor gender on outcome after heart Transplantation. J Heart Lung Transplant. 1992;11:701–707
  30. Prendergast TW, Furukawa S, Beyer AJ, Browne BJ, Eisen HJ, Jeevandandam V. The role of gender in heart transplantation. Ann Thorac Surg. 1998;65:88–94
  31. Johnson MR, Naftel DC, Hobbs RE, et al.  The incremental risk of female sex in heart transplantation (a multiinstitutional study of peripartum cardiomyopathy and pregnancy). J Heart Lung Transplant. 1997;16:801–812
  32. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation. 1998;97:2079–2090
  33. Bank AJ, Mir SH, Nguyen DQ, et al.  Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg. 2000;69:1369–1375
  34. Buz S, Drews T, Weng Y, et al.  Heart transplantation after mechanical circulatory support. Transplant Proc. 2000;32:583–584
  35. Koul B, Solem JO, Steen S, Casimir-Ahn H, Granfeldt H, Lonn UJ. HeartMate left ventricular assist device as bridge to heart transplantation. Ann Thorac Surg. 1998;65:1625–1630
  36. Jaski BE, Kim JC, Naftel DC, et al.  Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy. J Heart Lung Transplant. 2001;20:449–456
  37. Murali S, Kormos RL, Uretsky BF, et al.  Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation (the Pittsburgh experience). Am Heart J. 1993;126:896–904
  38. Chen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation (determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality). J Thorac Cardiovasc Surg. 1997;114:627–634
  39. Espinoza C, Manito N, Roca J, et al.  Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation (importance in the postoperative morbidity and mortality). Transplant Proc. 1999;31:2503–2504
  40. Tenderich G, Kerner MM, Stuettgen B, et al.  Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or > 5 Wood) predict early and long-term results after orthotopic heart transplantation?. Transplant Proc. 1998;30:1130–1131
  41. Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. Eur Heart J. 1999;20:148–156
  42. Aziz T, Burgess M, Rahman AN, Campbell CS, Yonan N. Cardiac transplantation for cardiomyopathy and ischemic heart disease (differences in outcome up to 10 years). J Heart Lung Transplant. 2001;20:525–533
  43. Delfontaine P, Brink M, Anwar A, Hayry P, Okura Y. Growth factors and receptors in allograft arteriosclerosis. Transplant Proc. 1999;31:111–114
  44. Hutchinson IV. The role of transforming growth factor beta in transplantation rejection. Transplant Proc. 1999;31:9s–13s
  45. Aziz TM, Burgess M, Hasleton PS, Yonan N, Deiraniya AK, Hutchinson IV. Transforming growth factor-beta (association with arteriosclerosis and left ventricular dysfunction after heart transplantation). Transplant Proc. 2001;33:2334–2336
  46. Mancini D, Beniaminovitz A, Edwards N, Chen J, Maybaum S. Survival of diabetic patients following cardiac transplant. J Heart Lung Transplant. 2001;20:168
  47. Czerny M, Sahin V, Zuckermann A, et al.  Diabetes affects long-term survival after heart transplantation. J Heart Lung Transplant. 2001;20:245; (abstract)
  48. Czerny M, Sahin V, Zuckermann A, et al.  Diabetes related complications in patients after heart transplantation. J Heart Lung Transplant. 2001;20:245; (abstract)
  49. Baker AM, Levine TB, Goldberg AD, Levine AB. Natural history and predictors of obesity after orthotopic heart transplantation. J Heart Lung Transplant. 1992;11:1156–1159
  50. Grady KL, Constanzo-Nordin MR, Herold LS, Sriniavasan S, Pifarre R. Obesity and hyperlipidemia after heart transplantation. J Heart Lung Transplant. 1991;10:449–454
  51. Kocher AA, Ankersmit J, Khazen C, et al.  Effect of obesity on outcome after cardiac transplantation. Transplant Proc. 1999;31:3187–3189
  52. Grady KL, Constanzo MR, Fisher S, Koch D. Preoperative obesity is associated with decreased survival after heart transplantation. J Heart Lung Transplant. 1996;15:863–871
  53. Grady KL, White-Williams C, Naftel D, et al.  Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality (a multi-institutional study of preoperative weight-height indices). J Heart Lung Transplant. 1999;18:750–763
  54. Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Constanzo MR. Report of consensus conference on candidate selection for heart transplantation—1993. J Heart Lung Transplant. 1995;14:562–571
  55. Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 1995;60:1462–1466
  56. Favaloro RR, Perrone SV, Moscoloni SE, et al.  Value of pre-heart-transplant psychological evaluation (long-term follow-up). Transplant Proc. 1999;31:3000–3001
  57. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549–562
  58. Stevenson LW, Koromos RL. Mechanical cardiac support 2000 (current applications and future trial design). J Am Coll Cardiol. 2001;37:340–370
  59. Kung RT, Yu LS, Ochs B, Parnis S, Frazier OH. An atrial hydraulic shunt in a total artificial heart (A balance mechanism for the bronchial shunt). ASAIO J. 1993;39:M213–217
  60. Weiss WJ, Rosenberg G, Snyder AJ, et al.  Steady state hemodynamic and energetic characterization of the Penn State/3M health care total artificial heart. ASAIO J. 1999;45:189–193
  61. Aaronson K, Schwartz J, Chen T-M, Wong K-L, Goin J, Mancini D. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667

PII: S1053-2498(02)00428-X

The Journal of Heart and Lung Transplantation
Volume 21, Issue 11 , Pages 1161-1173 , November 2002

Article Tools